Sakka Sophia Logo
mobileheader 6944205975 2107772274

Δημοσιεύσεις

  1. Kanaka-Gantenbein C, Margeli A, Pervanidou P, Sakka S, Mastorakos G, Chrousos G,  Papassotiriou I. Retinol Binding Protein-4 and Lipocalin-2 in Childhood and Adolescent Obesity: When Kids are not Just ″Small Adults″. Clinical Chemistry 2008 May; 54(7):1176-1182.
  2. Pervanidou P, Margeli A, Akalestos A., Sakka S, Papassotiriou I, Kanaka-Gantenbein C and  Chrousos GP.  Associations between N-terminal pro-Brain Natriuretic Peptide (NT- proBNP) and adiponectin concentrations depend on the degree of obesity in female adolescents: gender dimorphic findings. Hormone and Metabolic Research, 2009 Nov;41(11):829-33
  3. Sakka SD, Malamitsi-Puchner A, Loutradis D, Chrousos G, Kanaka-Gantenbein C. Euthyroid hyperthyrotropinemia in children born after in vitro fertilization. Journal of Clinical Endocrinology and Metabolism, 2009;94(4):1338-41
  4. Ntalla I, Dedoussis G, Yannakoulia M, Smart MC, Louizou E, Sakka SD, Papoutsakis C, Talmud PJ. ADIPOQ gene polymorphism rs1501299 interacts with fibre intake to affect adiponectin concentration in children: the GENe-Diet Attica Investigation on childhood obesity. European Journal of Nutrition. 2009 Dec;48(8):493-7
  5. Sakka SD, Loutradis D, Kanaka-Gantenbein C, Margeli A, Papastamataki M, Papassotiriou I, Chrousos GP. Absence of insulin resistance and low-grade inflammation despite early metabolic syndrome manifestations in children born after in vitro fertilization. Fertility and Sterility, 2010;94(5)1693-9
  6. Pervanidou P, Akalestos A., Sakka S, Papassotiriou I, Kanaka-Gantenbein C and Chrousos GP. Gender dimorphic associations between N-terminal pro-Brain Natriuretic Peptide (NT- proBNP), Body Mass Index and Blood Pressure in Children and Adolescents. Hormone Research, 2010;73(5):341-8
  7. Kanaka-Gantenbein, S.Sakka, GP.Chrousos. Assisted reproduction and its neuroendocrine impact on the offspring. Progress in Brain Research, 2010;182:161-74
  8. Papadogeorgou P, Roma E, Sassolas A, Orfanou I, Malliarou A, Sakka S, Chouliaras G. Chylomicron retention disease: report of two cases from a Greek island. Journal of Pediatric Endocrinology and Metabolism 2012;25(11-12):1191-4
  9. Roma E, Krini M, Hantzi E, Sakka S, Panayotou I, Margeli A, Papassotiriou I, Kanaka-Gantenbein C. Retinol Binding Protein 4 in children with Inflammatory Bowel Disease: a negative correlation with the disease activity. Hippocratia 2012;16(4):360-5
  10. Papadogeorgou P, Chouliaras G, Sakka S, Stefanaki K, Sassola A, Orfanou I, Malliarou MA, Roma E. Chylomicron retention disease. Annales Clinicae Paediatricae Universitatis Atheniensis, 2012;59(2):154-160
  11. Sakka SD, Margeli A, Loutradis D, Chrousos GP, Papassotiriou I, Kanaka-Gantenbein C. Gender dimorphic increase in RBP-4 and NGAL in children born after IVF: an epigenetic phenomenon? European Journal of Clinical Investigation 2013;43(5):439-48
  12. Metheniti D, Sakka S, Dracopoulou M, Kanaka-Gantenbein C, Chrousos GP, Pervanidou Decreased circulating 25-(OH) Vitamin D3 (25-(OH)D3) concentrations in obese female children and adolescents: Associations with Retinol Binding Protein-4 (RBP-4) and Lipocalin-2. Hormones 2013;12(3):397-404
  13. Sakka S, Siahanidou T, Voyatzis C, Pervanidou P, Kaminioti C, Lazopoulou N, Kanaka-Gantenbein C, Chrousos GP, Papassotiriou I. Elevated circulating levels of lipoprotein-associated phospholipase A2 in obese children. Clinical Chemistry and Laboratory Medicine. 2015 Jun;53(7):1119-25.
  14. Abbate R, Al-Daghri NM, Andreozzi P, Borregaard N, Can G, Caridi G, Carstensen-Kirberg M, Cioni G, Conte E, Cuomo R, Denis MA, Fakhfouri G, Fakhfouri G, Fiasse R, Glenthøj A, Goliasc G, Gremmel T, Herder C, Iemmolo M, Jing ZC, Krause R, Marrone O, Miazgowski B, Miazgowski T, Minchiotti L, Mousavizadeh K, Ndrepepa G, Niessner A, Ogayar Luque C, Onat A, Papassotiriou I, Ruiz Ortiz M, Sabico S, Schooling CM, Sakka SD, Sołtysiak P, Visseren FL, Wagner J, Wang XJ,Westerink J. Research update for articles published in EJCI in 2013. European Journal of Clinical Investigation 2015;45(10):1005-16
  15. Kumaran A, Sakka S, Dias R. Guideline review. Obesity in children- Recent NICE guidance. Archives of Disease in Childhood – Education and Practice Edition. 2017 Apr;102(2):84-88.
  16. Sakka S, Gafni RI, Davies JH, Clarke B, Tebben P, Samuels M, Saraff V, Klaushofer K, Fratzl-Zelman N, Roschger P, Rauch F, Högler W. Bone Structural Characteristics and Response to Bisphosphonate Treatment in Children With Hajdu-Cheney Syndrome. Journal of Clinical Endocrinology and Metabolism. 2017 Nov 1;102(11):4163-4172
  17. Saraff V, Sahota J, Crabtree N, Sakka S, Shaw NJ, Högler W. Efficacy and treatment costs of zoledronate versus pamidronate in paediatric osteoporosis. Archives of Disease in Childhood, 2018 Jan;103(1):92-94
  18. Nimri R, Dassau E, Segall T, Muller I, Bratina N, Kordonouri O, Bello R, Biester T, Dovc K, Tenenbaum A, Brener A, Šimunović M, Sakka SD, Nevo Shenker M, Passone CG, Rutigliano I, Tinti D, Bonura C, Caiulo S, Ruszala A, Piccini B, Giri D, Stein R, Rabbone I, Bruzzi P, Omladič JŠ, Steele C, Beccuti G, Yackobovitch-Gavan M, Battelino T, Danne T, Atlas E, Phillip M. Adjusting insulin doses in patients with type 1 diabetes who use insulin pump and continuous glucose monitoring: Variations among countries and physicians. Diabetes, Obesity and Metabolism, 2018 Oct;20(10):2458-2466.
  19. Uday S, Sakka S, Davies JH, Randel T, Arya V , Brain C, Tighe M, Allgrove J, Arundel P, Pryce R, Hogler W, Shaw NJ. Elemental formula associated with hypophosphataemic rickets. Clinical Nutrition 2019 Oct;38(5):2246-2250
  20. Vlachopoulos C, Kosteria I, Sakka S, Gkourogianni A, Terentes-Printzios D, Koutagiar I, Skoumas I, Miliou A, Papassotiriou I, Gardikioti V, Loutradis D, Chrousos G, Kanaka-Gantenbein C, Tousoulis D. PCSK9 and Lp(a) levels of children born after assisted reproduction technologies. The Journal of Assisted reproductions and genetics. 2019 Jun;36(6):1091-1099
  21. Sakka SD, Mann K, Lachlan K, Davies JH, Bateman M, Holder-Espinasse M, Arya VB. Haematological chimerism masquerading as disorder of sex development. Clinical Endocrinology (Oxf). 2020 May;92(5):487-489.
  22. Sakka SD, Cheung MS. Management of primary and secondary osteoporosis in children. Therapeutic Advances in Musculoskeletal Disease, 2020 Nov 2;12:1759720X20969262
  23. Ponmani C, Sakka SD,Wickramarachchi C, Ajzensztejn M, Kanumakala S, Redpath Y, Hulse T. Characteristics of New-Onset Paediatric Type 1 Diabetes in the COVID-19 Pandemic – Α Multicentre Perspective. Ann Pediatr. 2021; 4(1): 1065
  24. Ponmani C, Sakka SD, Hulse T. Severe Diabetic Ketoacidosis in Two Children with New Onset type 1 Diabetes after SARS-CoV-2 Infection. Curr Res Diabetes Obes J 14(3): CRDOJ.MS.ID.555887 (2021)

 

 

 

Desktop CTA Mobile CTA